Skip to content
Medical Health Aged Care

Vasileios Mingos Joins Health-ISAC as European Operations Director

Health-ISAC, INC. 2 mins read

Leading Health-ISAC's European efforts to improve global security and patient safety

ORMOND BEACH, FL / ACCESSWIRE / August 1, 2023 / Health Information Sharing and Analysis Center (Health-ISAC) has announced Vasileios Mingos has joined the organization and will serve as European Operations Director. Mingos will oversee all Health-ISAC European Operations, the European Regional Threat Operations Center, and represent Health-ISAC throughout Europe.

Health-ISAC logo with tagline

In his role, Mingos will continue to expand a regional Health-ISAC presence in Europe by collaborating directly with member organizations, including some of the world's largest healthcare firms. In addition, he will develop and enhance partnerships with key regional stakeholders such as industry associations, government agencies, CERTs, and law enforcement.

"We are excited to bring Vasileios onboard for this important mission," says Denise Anderson, President and CEO of Health-ISAC. "He brings a passion as well as deep experience in healthcare cybersecurity to the position. Having him as part of the global team helps solidify Health-ISAC's commitment to securing healthcare globally and serving our members and the health sector in Europe."

Mingos has a strong background in building and leading information security teams since 2017 and his previous work experience includes developing and implementing Eurofins' Security Operations Center and Security Intelligence program in Europe.


Health-ISAC - a non-profit, private sector, member-driven organization - plays an essential role in providing situational awareness around cyber and physical security threats to the Healthcare Sector so that companies can detect, mitigate, and respond to ensure operational resilience. Health-ISAC connects thousands of healthcare security professionals worldwide to share peer insights, real-time alerts, and best practices in a trusted, collaborative environment. As the go-to source for timely, actionable, and relevant information, Health-ISAC is a force-multiplier that enables healthcare organizations of all sizes to enhance situation awareness, develop effective mitigation strategies and proactively defend against threats every single day.


Contact Information:

Julia Annaloro
Marketing and Communications II



View source version on

More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.